CTRI/2024/05/068127
Not yet recruiting
Phase 2
Management of Diabetes Mellitus Type 2 with Homoeopathic Medicines selected by Using Synthesis Repertory and Preparation of Repertory of Diabetes and Therapeutics for the same - DMSR
Rajkot Homoeopathic medical College0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Rajkot Homoeopathic medical College
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of both sexes \& age group between 35\-65 years of both the sexes will be considered.
- •All socio\-economical classes will be considered.
- •Patients having HbA1c less than or equals to 8%.
- •Pre\-diagnosed cases which are under any system of treatment, but yet not having relief or improvement \& willing to take homoeopathy.
Exclusion Criteria
- •Complicated cases with advanced \& irreversible pathological conditions.
- •Patients who do not follow the advise \& dietary restrictions given by the physician strictly.
- •Cases with more than 3 irregular follow\-ups.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Treatment Strategies in Patients with Type 2 Diabetes Mellitus Not Achieving Glycemic Control while on Therapy with Premixed Insulin Analogues and Metformin: A Comparison of Insulin Lispro MM Intensive Mixture Therapy with Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70 - S019EUCTR2006-003076-35-HUEli Lilly and Company Ltd.270
Recruiting
Phase 3
Prevention and management of diabetic complications by an Ayurvedic formulatioHealth Condition 1: null- Type-2 Diabetes mellitusCTRI/2015/01/005366SRM University1,000
Completed
Phase 4
OpT2mise glucose control in type 2 Diabetes Mellitus (DM) with insulin pump therapySugardisease10018424NL-OMON38266Medtronic B.V.60
Completed
Phase 1
Treating To Target in Type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN51125379ovo Nordisk Limited (UK)700
Completed
Not Applicable
Salutogenic Intervention for Diabetes Type 2: the SALUD-studyType 2 Diabetes Mellitusadult-onset diabetes10018424NL-OMON52561Wageningen Universiteit56